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Abstract 
The purpose of this project was to evaluate the effectiveness of a practice-based 
dermoscopy training program for dermatology healthcare providers in order to improve 
their technique of performing clinical skin exams for the early detection of melanomas.  
The overall incidence of melanoma continues to rise.  More than 75% of all skin 
cancer deaths are from melanoma.  Advanced melanoma spreads to lymph nodes and 
internal organs and can result in death.  One American dies from melanoma almost every 
hour (American Cancer Society [ACS], 2009).  Early diagnosis and excision are essential 
to reduce morbidity and to improve patient survival.  
This one-group before-and-after study design utilized a convenience sample of 
three dermatology healthcare providers (DHPs).  The primary investigator conducted a 
retrospective review of the pathology logs for each provider.  The time frame for the 
review was a three-month period in 2010, which represented the same time frame that the 
study was conducted in 2011.  The DHPs participated in a four-hour training workshop 
that included pattern analysis recognition using dermoscopy.  Following the workshop, 
each DHP was given a DermLite 3Gen DL100 to use in practice when performing 
clinical skin examinations.  All DHPs completed a data collection sheet to document their 
pattern of decision making with and without a DermLite.  The outcome of interest was 
the use of dermoscopy by DHPs to demonstrate an increased detection of melanoma 
when compared to naked-eye examination.  The outcome was evaluated 12 weeks post-
workshop training. 
There were 120 evaluations made with the DermLite as compared to the naked 
eye.  The overall agreement was 0.52, AC1 coefficient (95% CI) was 0.36 (0.30, 0.42),   
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p < .001, and kappa coefficient (95% CI) was 0.27 (0.20, 0.43), p < .001.  Overall, the 
risk of lesion under exam being suspicion for skin cancer was higher on 27.5% (33 out of 
120) of the evaluations and lower on 20.8% (25 out of 120) evaluations.  The risk of 
lesion was evaluated the same on 51.7% (62 out of 120) of the evaluations.  This is an 
indication of “Poor” agreement between the two methods.  The diagnosis and disposition 
made using DermLite compared to naked-eye results for both coefficients provided an 
“Intermediate to Good” agreement between the two methods in assigning diagnosis and 
disposition.  This indicates that there is no difference between DermLite and naked-eye 
evaluations. 
More studies are needed in order to provide better evidence on the value of 
dermoscopy in clinical practice at the Dermatology and Laser Center.  Future projects 
should be more explicit regarding the methods used and lesion selection in order to better 
understand the benefits of dermoscopy. 
    
  
 
 
 
 
 
 
 
Chapter One: Introduction 
 Chapter One introduces the challenges/problems with performing a clinical skin 
examination with the use of dermoscopy, provides an abbreviated literature review, and 
briefly describes the project.  Chapter One also includes the research questions and 
definition of terms.   
Challenges 
 Melanoma, the most serious form of skin cancer, is characterized by the 
uncontrolled growth of pigment-producing cells.  A melanoma might appear on the skin 
suddenly without warning, but it can also develop on an existing mole.  The overall 
incidence of melanoma continues to rise.  More than 75% of all skin cancer deaths are 
from melanoma.  Advanced melanoma spreads to lymph nodes and internal organs and 
can result in death.  One American dies from melanoma almost every hour (ACS, 2009).  
People of all ages are affected by melanoma, causing more years of lost life than any 
other cancer, excluding leukemia (High, 2008).  
 Diagnostic criteria for the diagnosis of melanoma have changed since the 1960s 
and 1970s, when melanomas were diagnosed based on itching, bleeding, and ulceration 
of the tumor.  Once the symptoms were observed, however, the prognosis was very poor. 
The ABCD rule was introduced in the 1980s.  This rule is based on simple clinical 
morphological features of melanoma: asymmetry, border irregularity, color variation, and 
a diameter greater than five millimeters.  The worldwide use of the ABCD rule has 
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allowed for early detection of some melanomas.  To improve on this rule, the letter E was 
added in 2004 as the fifth criterion and explains evolution of the lesion over time 
(Guibert, Mollat, Ligen, & Dreno, 2000). 
There are two problems associated with the ABCD rule.  First, the rule only has 
65 - 80% sensitivity because the rule does not allow for melanomas less than five 
millimeters.  Melanomas can be less than five millimeters and have a regular shape and 
color, which would consequently be falsely classified as benign.  Second, benign 
melanocytic nevi can mimic melanomas, causing unnecessary excisions to be performed 
on a daily basis (Argenziano & Soyer, 2001).   
            Contributing factors that place patients at high risk for developing melanoma 
include sun exposure, personal history of atypical moles, personal or family history of 
melanoma, more than 75 - 100 moles on the body, repeated sun burns, fair skin with red 
or blonde hair, and chronic tanning bed use.  A significant increased risk of melanoma is 
linked to the intermittent exposure to UV radiation (Cattaruzza, 2000).  The American 
Cancer Society (2007) concluded that the most preventive tools available are full body 
examinations by a health care provider, sun protection, and sun avoidance.   
            Melanoma presents a substantial clinical challenge to healthcare providers.  The 
early detection of this skin cancer provides the patients with the best chance for a cure.  
The frequency of melanoma has increased over the last twenty years.  Therapies for 
metastatic melanoma are inadequate, making the best treatment early diagnosis with 
immediate surgical excision of the tumor.  There is a critical need to have current 
diagnostic practices evaluated in order to have the best technique used when performing a 
clinical skin exam (Argenziano & Soyer, 2001). 
3 
 
 Dermoscopy is an in vivo diagnostic technique that is noninvasive and used to 
magnify the skin.  Dermoscopy allows the colors in the structures of the epidermis, 
dermo-epidermal junction, and papillary dermis to show detail far beyond the ability of 
the unaided eye.  The portable polarized imaging system has made it convenient for the 
healthcare provider to examine a suspicious lesion for possible malignancy.  
Dermoscopy, used for many years in Europe, is currently becoming the standard of care 
for clinical skin examination (Arrazola, Mullani, & Abramovits, 2005).  
Pattern analysis is the procedure used by most dermatology healthcare providers 
when conducting a skin examination.  The first step requires the examiner to determine if 
the lesion is melanocytic or nonmelanocytic.  The identification of the pigmented 
network, aggregated dots and globules, branched streaks, and homogenous blue 
pigmentations are all highly characteristic of pigmented lesions.  Once the examiner has 
identified the lesion as pigmented the next step is to determine if the lesion is clinically 
benign or malignant.  Benign lesions have global features that are uniform.  Malignant 
lesions have atypical global features.  There are three criterions that are important in 
distinguishing melanoma from benign lesions: asymmetry, atypical network, and blue 
white structures (Johr, Soyer, Argenziano, Hofmann-Wellenhof, & Scalvenzi, 2004). 
Abbreviated Literature Review 
 The diagnostic accuracy of dermoscopy in detecting melanoma was assessed by 
performing a meta-analysis of eight studies that met the selection criteria from the 672 
studies obtained in the MEDLINE database.  A meta-analysis is a statistical procedure 
that integrates the results of several studies.  Once data are combined, a quantified and 
reproducible synthesis of data can provide an objective appraisal of the evidence.  A well 
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conducted meta-analysis should also diminish the bias of each study (D’Agostino & 
Weintraub, 1995). 
 The eight retained studies came from dermatology departments and were 
published between 1993 - 2000.  All studies used histological findings as a standard 
criterion.  Fifty percent of the studies had histological findings verified by an external 
review or from a consensus of at least two observers.  Clinical and dermoscopic 
examinations were conducted in all studies (Bafounta, Beauchet, Aegerter, & Saiag, 
2001). 
 The results determined that healthcare providers trained in dermatology and 
working in a specialized clinic with dermoscopy experience yield increased detection of 
melanomas compared to the naked eye.  The conclusion of the study was favorable for 
the use of dermoscopy.  One of the studies in the meta-analysis recommended that 
healthcare providers working in dermatology should take the necessary steps to master 
this useful tool (Bafounta et al., 2001). 
The Problem 
 The overall incidence of melanoma continues to rise.  More than 75% of all skin 
cancer deaths are from melanoma.  Advanced melanoma spreads to lymph nodes and 
internal organs and can result in death.  One American dies from melanoma almost every 
hour (ACS, 2009).  Early diagnosis and excision are essential to reduce morbidity and 
improve patient survival.  
 There is no current recommendation from the American Academy of 
Dermatology regarding the use of dermoscopy to aid detection of melanoma during a 
clinical skin examination.  Despite the lack of recommendations, some experts 
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acknowledge full body skin cancer screening as a simple, practical way to reduce skin 
cancer incidence and mortality.  Dermoscopy has also been shown to be a useful 
diagnostic tool. 
 Therefore, the purpose of this project was to evaluate the effectiveness of a 
practice-based dermoscopy training program for dermatology healthcare providers in 
order to improve their technique of performing clinical skin exams for the early detection 
of melanomas.  
Project Description 
 This project was designed to improve clinical skin examination techniques in 
healthcare providers working in dermatology at a dermatology and laser practice in 
northeast Florida.  The practice strategic plan includes keeping up with the latest 
advancements in dermatology in order to provide patients with the most up-to-date 
services available.  A prospective study to examine whether provider education with a   
four-hour training course delivered by an expert in dermoscopy, regarding the science 
behind the regular use of dermoscopy, while also using pattern analyses, will increase the 
number of melanomas diagnosed over a three-month time period in the practice.  
 A board certified dermatologist with expertise in dermoscopy was asked to 
deliver the four-hour training workshop.  One nurse practitioner currently using 
dermoscopy, one dermatologist not currently using dermoscopy, and one physician 
assistant not currently using dermoscopy attended the lecture.  The practice pathology 
logs were assessed at a three-month period before the training and a three-month period 
after the training.  The number of pathology reports that were positive for melanoma 
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were evaluated by each healthcare provider.  Each healthcare provider was provided with 
a Derm-lite DL100 dual polarized LED made by 3Gen LLC to use during the study.  
Research Questions 
 The following research questions guided the literature review: 
      1.  What is the difference in the detection of melanoma in dermatology when    
           dermoscopy is used versus the naked eye? 
     2.   Does dermoscopy decrease the number of biopsies of benign skin lesions?   
Definition of Terms 
 Dermoscopy: A vivo noninvasive diagnostic technique that magnifies the skin in 
such a way that color and structures in the epidermis, dermo-epidermal junction, and 
papillary dermis become visible (Johr et al., 2004, p. 1).  
 Melanoma: A malignancy of melanocytes that occur in the skin, eye, ears, 
gastrointestinal tract, leptomeninges, and oral and genital mucous membranes (Habif, 
2004, p. 786). 
 Sensitivity: The proportion of individuals with the disease who are correctly 
diagnosed by the test (Petrie & Sabin, 2009, p. 171).  
  Specificity: The proportion of the individuals without the disease who are 
correctly identified by a diagnostic test (Petrie & Sabin, 2009, p. 172). 
 Asymmetry: Asymmetry of color and structure in one or two perpendicular axes 
(Johr et al., 2004, p. 2) 
 Atypical network: Pigment network with irregular holes and thick lines (Johr et 
al., 2004, p. 2). 
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 Blue-white structures: Any type of blue and/or white color (Johr et al., 2004, p. 
2). 
 In summary, Chapter One introduced the challenges/problems with melanoma 
diagnosis, the potential benefits of using dermoscopy when performing clinical skin 
examinations, an abbreviated literature review, and a brief description of the proposed 
project.  Research questions used to search the literature and definitions were also 
provided. 
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Chapter 2: Review of the Literature 
 A critical appraisal of the literature will be presented in this chapter in order to 
determine if completing a full skin examination with the aid of dermoscopy would 
improve the early detection of melanoma compared to the unaided eye examination.  A 
literature search was conducted using Medline, CINAHL, and ScienceDirect for high 
level evidence using the following key terms: dermoscopy, melanoma, diagnosis, and 
skin examination.  Articles dating back to 1997 that had two of the key terms were 
reviewed.  Two other websites were used to locate research articles on dermoscopy: 
Journal of the American Academy of Dermatology (www.eblue.org) and Archives of 
Dermatology (www.archdermtol.com).  
Melanoma 
 Melanoma is a fatal disease requiring early diagnoses and treatment.  Recognition 
of early melanoma is a daily challenge for dermatology healthcare providers.  Morbidity 
and mortality related to melanoma of the skin has increased significantly in recent years.  
There is a strong inverse correlation between survival rates and tumor thickness, with no 
effective therapy for advanced melanoma.  Early diagnosis and excision of the tumor is 
essential to reduce the morbidity and mortality rates related to melanoma  
(Bafounta et al., 2001).   
 Early diagnosis of melanoma is of critical importance for patient prognosis.  
Patients with a cutaneous melanoma thinner than 1 mm have a 95% 5-year survival rate, 
9 
 
while patients with an ulcerated melanoma greater than 4 mm thick have a 45% 5-year 
survival rate (Balch et al., 2001).  Diagnosing melanoma clinically will allow early 
detection and surgical excision of thin melanomas.  Excision is the only efficient 
treatment available (Tsao, Atkins, & Sober, 2004).  Melanomas should be considered 
when a patient reports a new pigmented lesion or a change in an existing mole.  In order 
to decrease mortality rates early, detection of melanoma is key (Marks, 1996). 
 Dermoscopy 
 Dermoscopy is a noninvasive in vivo technique used to examine the structures 
that lie beneath the skin surface; it has increased the understanding of the clinical 
morphology of skin lesions.  Dermoscopy allows subsurface structures in the epidermis, 
dermoepidermal junction, and papillary dermis to be seen, structures that are otherwise 
invisible to the naked eye (Grin, Friedman, & Grant-Kels, 2002).     
 Dermoscopy is a diagnostic test with high levels of sensitivity and specificity.  
Diagnostic tests are helpful if the results will alter the clinical management of the disease, 
allowing for better patients outcomes.  In the case of a pigmented skin lesion, 
dermoscopy helps the provider to decide if excision of the lesion is necessary (Mayer, 
1997). 
History of Dermoscopy    
 Skin surface microscopy started hundreds of years ago.  In 1663, Johan Kolhaus 
first looked at nail fold vessels with a microscope.  Unna published a paper in 1893 
entitled “Diaskopie”, which described the use of oil immersion with a microscope for 
skin surface microscopy.  The term dermatoscopy was introduced in the 1920s with the 
introduction of a new diagnostic tool resembling a binocular microscope with a built-in 
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light source for the examination of the skin.  The term dermoscopy was introduced in 
1950 when a dermatologist used the instrument for the evaluation of pigmented skin 
lesions.  In 1971, Rona MacKie identified the advantage of surface microscopy for the 
improvement of preoperative diagnosis of pigmented skin lesions and for the differential 
diagnosis of benign versus malignant skin lesions (Grin et al., 2002).  The technique 
utilized in the 21st century was studied and refined by Austrian, German, and Italian 
investigators.  In 1989, the first Consensus Conference on Skin Surface Microscopy was 
held in Hamburg, Germany, and in 2001 the Consensus Net Meeting on Dermoscopy was 
convened in Rome, Italy.  The goal of both meetings was to standardize the definitions of 
structures seen in benign and malignant pigmented skin lesions (Soyer, et al., 2001).             
Literature Review 
 In appraising the literature, multiple levels of evidence were reviewed.  Articles 
on dermoscopy ranging from case studies to systematic reviews were all appraised.  This 
paper reviews the highest levels of evidence: randomized studies, meta-analysis, and 
systematic reviews. 
Randomized Control Trial 
 A randomized control trial (RCT) by Carli et al. (2004) enrolled 913 patients with 
pigmented skin lesions.  The study was conducted at a pigmented lesion clinic to assess 
the difference in lesion management between combined examination (naked eye and 
dermoscopy) and conventional naked-eye examination in the evaluation of melanoma.  
The patients were randomized to either combined examination with mandatory excision 
of equivocal lesions or to conventional naked-eye examination for melanoma with 
mandatory excision of equivocal lesions.  The study showed that the examination of a 
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pigmented skin lesion using dermoscopy allows for the visualization of morphologic 
features not visible to the naked eye.  This allowed trained observers to reach a more 
reliable diagnosis of most skin lesions, including melanoma, compared to conventional 
naked-eye examination.  The study was done to investigate the impact of the addition of 
dermoscopy to conventional naked-eye examination in routine melanoma screening.  The 
findings in the study were confirmed by means of a multivariate analysis.  The study 
demonstrated that the addition of dermoscopy to the routine screening of melanoma is 
associated with clinically relevant lesion management, reducing the number of cases of 
excisional biopsies.  The authors hypothesize that the reduction of surgical excisions 
aimed at diagnostic verification was obtained through better classification of equivocal 
lesions compared to conventional screening, lowering the number of false-positive 
diagnoses.  The debate continues over the issue of false-negative diagnoses by 
dermoscopy.  Based on formal studies on melanoma classification, dermoscopy does not 
have 100% sensitivity; this makes excluding false-negative results unlikely.  This could 
be due to the high number of benign lesions that are excised in an effort to avoid leaving 
a melanoma unexcised.   
One study in the literature addressed the issue of false-negative results after 
dermoscopy.  This was done through a local cancer registry that showed 3.7% of 
melanomas left unexcised after screening.  Two out of 55 cases of melanomas examined 
were not excised.  This resulted in a sensitivity of 96.3% (Stanganelli, Serafini, & Bucch, 
2000).   
 An RCT was performed to determine if the use of dermoscopy with standard 
clinical examination improves the accuracy of primary care physicians to triage lesions 
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suggestive of skin cancer.  A total of 73 physicians were given a one-day training course 
in dermoscopy evaluation and skin cancer detection.  Following the training, the 
providers were randomly assigned to the dermoscopy group or the naked-eye 
examination group.  The providers evaluated 2,522 patients with skin lesions.  The 
lesions were scored as “benign” or “suggestive of skin cancer”.  All patients were then 
evaluated and scored by two expert dermatologists who used dermoscopy.  The 
dermatologists were blinded regarding patients’ randomization schedules.  The lesions 
that the dermatologist examined as being suggestive of skin cancer were excised and 
diagnosed histopathologically.  Histopathologic examination of equivocal lesions 
demonstrated 23 malignant lesions missed by naked-eye examination and 6 by 
dermoscopy.  The investigators concluded that dermoscopy improves the primary care 
physicians’ ability to triage lesions suggestive of skin cancer (Argenziano et al., 2006).  
 In an RCT by Westerhoff, McCarthy, and Menzies (2000), 74 practicing primary 
care physicians (PCPs) completed a pre-test of 50 melanomas and 50 atypical non-
melanoma pigmented skin lesions (PSLs) containing matched clinical and surface 
dermoscopy photographs.  PCPs were randomized between dermoscopy education 
intervention or control group followed by an identical post-test. 
 Before training, there were no significant differences in the pre-test results 
between the clinical and the surface dermoscopic diagnosis on melanoma or non-
melanoma PSL.  No significant differences were seen in the pre-test results between the 
education intervention group and the non-education intervention group.  After training, 
the clinical diagnosis of melanoma was compared by looking at the clinical images only.  
There was a significant improvement in the education intervention group between the 
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pre-test (54.6%) and post-test (62.7%) results (P = .007).  In contrast there was no 
difference between the clinical melanoma diagnosis between the pre-test and post-test in 
the non-intervention group (P =.21).  This is an important indication that the education 
intervention also created a heightened awareness of the clinical signs of melanoma.  This 
is consistent with the content of the intervention that contains both clinical and 
dermoscopic images of PSL (Menzies, Crotty, Ingvar, & McCarthy, 1996).          
 Following the education intervention, dermoscopy further improved the PCPs 
diagnosis of melanoma.  The clinical correct diagnosis was 62.7% compared with 75.9% 
when dermoscopy was utilized (p = .000007).  The difference between dermoscopy and 
clinical score in pretest versus post-test (p = .0004); this supports that the education 
intervention was responsible for the improved diagnostic accuracy.  
Meta-Analysis  
A meta-analysis by Kittler, Pehamberger, Wolff, and Binder (2002) reviewed 
relevant studies from a MEDLINE search from January 1987 to December 2000.  The 
search produced 157 articles, of which 116 were excluded because they did not report 
sufficient data for the sensitivity and specificity to be estimated.  Studies that involved 
computerized image analysis were also excluded.  The final sample included 27 studies, 
of which 20 were identified by the MEDLINE search, three by manual searches of the 
reference list of retrieved articles, and four by communication with experts.  
The eligible studies were classified with no masking.  Two readers were 
responsible for the review using defined characteristics important for the assessment of 
diagnostic tests.  From each report the authors’ names, year of publication, description of 
pigmented skin lesions, experience of examiners, independence of clinical and 
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histological assessment, type of diagnostic algorithm, mode of presentation, and results 
were extracted.  
 Most of the lesions were verified by excision.  Only one study looked at benign 
lesions that were not excised.  In 14 studies (52%), the diagnostic accuracy for melanoma 
with and without dermoscopy was directly compared.  In three studies (11%), two or 
more diagnostic algorithms for dermoscopy were compared.  Pattern analysis was used in 
16 studies (59%), the ABCD rule in seven (26%), and modified pattern analysis in 
conjunction with a scoring system in seven (26%).  Five studies (19%) compared the 
performance of experts and non-experts, and two (7%) assessed the influence of training 
on the performance of non-experts.  Dermatologists were included in 26 of the 27 studies 
that were reviewed.  
The use of dermoscopy yielded a higher diagnostic accuracy for melanoma 
compared to the unaided eye when used by an experienced examiner.  The studies found 
that the diagnostic performance of dermoscopy was significantly increased when a group 
of examiners made the diagnosis in consensus.  A consensus diagnosis may not be 
practical in most clinical settings.  The examiners’ experience with dermoscopy 
determines the diagnostic accuracy of the tool.  Dermoscopy applied by non-experts is 
equal to the unaided eye examination.  This is a significant finding that underlines the 
importance of the need for training in order to utilize dermoscopy as a diagnostic tool 
(Binder et al., 1997). 
 Diagnostic accuracy for melanoma was found to be higher with dermoscopy 
(odds ratio 4.0, 95% CI: 3.0 - 5.0) than without dermatocopy (odds ration 2.7, 95% CI: 
1.9 - 3.4).  There is an overlap in the confidence intervals, which may cause dermoscopy 
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and non-dermoscopy melanoma diagnosis to be equal in regards to the odds ratio value.  
There was no significant difference in diagnostic accuracy arising from the use of 
different dermoscopy diagnostic algorithms.  The experience of the examiners is the 
significant factor.  The odds ratio was 3.8 (95% CI: 3.3 - 4.3) for experts versus 2.0 (95% 
CI: 1.4 - 2.6) for non-experts.  The results of this meta-analysis documents that 
dermoscopy improves the diagnostic accuracy for melanoma compared to inspection by 
the unaided eye.  Dermoscopy requires a basic training course and continual practice 
following training in order to learn the skill.  Dermoscopy is not recommended for 
untrained users.  A diagnosis involving two or more experts is recommended to yield the 
highest possible diagnostic accuracy (Kittler et al., 2002). 
 The meta-analysis by Bafounta et al. (2001) identified 564 articles from 
MEDLINE, 223 from EMBASE, 117 from PASCAL-BIOMED, and 2 doctoral theses 
from BIUM database.  Duplicates were eliminated, making the final count 672.  The 
authors selected studies that had a spectrum of lesions well described, histological 
findings as standard criterion, and calculated or calculable sensitivity and specificity. 
Only eight of the 672 retrieved studies met the inclusion criteria. 
 The eight retained studies came from dermatology departments and were 
published between 1993 and 2000.  The settings were dermatology clinics or PSL clinics.  
Two of the studies were performed based on images obtained from a computerized 
database.  Six of the studies recorded dermoscopy results in vivo.  Four studies had 
histological findings verified by an external review or obtained by agreement between at 
least two observers (Stanganelli et al., 2000).  
16 
 
 The studies had 2193 total lesions, of which 328 (15%) were melanomas.  The 
sample size among the studies varied from 15 to 824 lesions.  Melanoma lesions 
represented 3% to 49% of the excised lesions.  Most of the melanomas were thin (< 0.76 
mm) from what was obtained in the four studies that provided melanoma thickness 
information.  The number of lesions represented as non-melanoma totaled 1865 (85%) 
and their histologic findings were detailed in all but one study (Stanganelli et al., 2000); 
theses lesions were mainly melanocytic lesions (67% - 100% of all non-melanoma PSLs).  
There was no demographic information given on any of the patients included in the 
studies.   
 The authors used the summary receiver operating characteristic curves of clinical 
and dermoscopic evaluations of melanoma, which indicated that dermoscopy had a 
significantly higher discriminatory power, with an estimated odds ratio of 76 (95% CI: 25 
- 223) versus 16 (95% CI: 9 - 31) for naked-eye examination (p = .008).  Similar values 
were seen with the weight least squares, the robust resistant line, and other exploratory 
data analysis methods (Moses, Shapiro, & Littenberg, 1993).       
 The authors concluded that more studies need to be conducted within 
dermatology clinics.  An increased number of melanoma and benign PSLs need to be 
evaluated.  More studies to evaluate the false-negative results need to be conducted.    
 Vestergaard, Macaskill, Holt, and Menzies (2008) conducted a meta-analysis on 
prospective studies of consecutive patients in a clinical setting to evaluate the evidence 
for improved diagnostic accuracy when using dermoscopy in addition to naked-eye 
examination for accurate clinical diagnosis of melanoma.  Nine studies met the criteria 
and were included in the review.  According to the authors, the diagnostic odds ratio was 
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estimated to be 15.6 times higher for dermoscopy than for naked-eye examination. (95% 
CI: 2.9 - 83.7, p = .016).  The wide CI reflects heterogeneity in the relative accuracy 
between studies.  The summary estimate of sensitivity was higher for dermoscopy (0.90, 
95% CI: 0.80 - 0.95) than for naked-eye examination alone (0.71, 95% CI: 0.59 - 0.82), 
with an estimated difference of 0.18 (95% CI: 0.09 - 0.27, P = .0002).  There was no 
statistical evidence of a difference in specificity: dermoscopy 0 - 90, 95% CI: 0.57 - 0.98; 
naked-eye examination 0.81, 95% CI: 0.48 - 0.95; difference 0.09, 95% CI: 0.06 - 0.23,  
P = .18. 
This meta-analysis provides evidence that clinical examination with the use of 
dermoscopy is more accurate than the naked eye alone for discriminating melanoma from 
non-melanoma in suspicious skin lesions for clinicians with at least minimal training in 
dermoscopy.  The results of this study were consistent with previous meta-analysis, 
including studies that utilized mainly experts in clinical and experimental settings.  Like 
other diagnostic techniques, some training in dermoscopy is needed to be able to achieve 
improvement in diagnostic accuracy.  Studies have shown that when dermoscopy is used 
in an experimental setting by dermatologists with no formal training in the technique, the 
diagnostic performance will be decreased (Binder et al., 1997).  
Systematic Review     
 Mayer (1997) conducted a systematic review of six articles that each compared 
diagnostic accuracy of dermoscopy to clinical diagnosis in order to assess their usefulness 
in clinical practice.  Five of the six studies compared dermoscopy with clinical diagnosis.  
Positive likelihood ratios for dermoscopy diagnosis of melanoma ranged from 2.9 to 
10.3.  Two studies found that dermoscopy had higher sensitivity than non-dermatoscopy.  
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One study found no difference in diagnostic accuracy.  Dermoscopy had a higher 
sensitivity when performed by expert examiners.  This sensitivity was decreased when 
the dermoscopy was performed by healthcare providers not trained in the use of 
dermoscopy (Binder et al., 1995). 
 Nachbar et al. (1994) compared two forms of dermoscopy with and without 
explicit structured diagnostic criteria, but combined with clinical diagnosis.  They found 
that dermoscopy with structured ABCD criteria had higher sensitivity and specificity than 
dermoscopy performed without the use of the ABCD criteria.  Clinical diagnosis varied 
widely in sensitivity and specificity between the studies.  This could have been due to the 
lesions varied in their ease of diagnosis.  Observers may have varied in their ability to 
make the diagnosis.  The studies provided results that favored handheld monocular 
demoscopy with 10 times magnification.  Handheld dermoscopy devices are most 
relevant to clinical practice.  Cristofolini, Zumiani, Bauer, Cristofolini, Bpi, and Micciolo 
(1994) found that dermoscopy with pattern analysis criteria had slightly higher sensitivity 
(88%) and specificity (79%) than clinical diagnosis performed with the use of the 
ABCDE criteria. 
 The systematic review by Rajpara, Botello, Townend, and Ormerod (2009) 
retrieved 765 articles from with 30 studies eligible for inclusion.  The review shows 
strong diagnostic performance by dermoscopy and artificial intelligence as evidence by 
diagnostic odds and likelihood ratios.  The review on dermoscopy showed it improves 
diagnostic accuracy of melanoma diagnosis for experienced examiners.  There was no 
significant difference between different algorithms.  The diagnostic performance of 
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dermoscopy improved when the diagnosis was made by a group of examiners in 
consensus and diminished as the prevalence of melanoma increased.     
 Multiple comparisons were done of the different dermoscopy algorithms.  There 
was no significant difference in the overall diagnostic performance of the different 
dermoscopy algorithms.  Dermoscopy showed significantly higher specificity than 
artificial intelligence (p < .001) but lower sensitivity (p = .076).  The review on 
diagnostic accuracy of artificial intelligence showed that melanoma diagnosis by 
computer is as accurate as an expert dermatologist under experimental conditions.           
 The computer diagnosis performance was better for studies that used dermoscopic 
images than for studies that used clinical images.  The studies in this present review were 
performed on databases of previously collected lesions rather than in the clinical setting.  
The external validity of these studies needs to be interpreted with caution (Rajpara et al., 
2009)      
Conclusion 
 Evidence from systematic reviews showed that dermoscopy yields greater 
diagnostic accuracy than naked-eye examination.  There were no effects found from the 
use of different dermoscopy diagnostic algorithms.  Diagnostic accuracy of dermoscopy 
is dependent upon the degree of experience the examiner has with using dermoscopy.  
The systematic review by Mayer (1997) estimated the likelihood ratios for a positive 
diagnosis of melanoma by dermoscopy as having a range of 2.0 - 10.3.  The systematic 
review by Bafounta et al. (2001) found the sensitivity of dermoscopy to have a range of 
75 - 96% and specificity of 79 - 98%.  The odds ratio for diagnosis of melanoma by 
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dermoscopy was 76 (95% CI: 25 - 223) versus 16 (95% CI: 9 - 31) for naked-eye 
examination (p = .008). 
A meta-analysis by Kittler et al. (2002) found diagnostic accuracy for melanoma 
to be higher with dermoscopy (odds ratio 4.0, 95% CI: 3.0 - 5.1) than without 
dermoscopy (odds ratio 2.7, 95% CI: 1.9 - 3.4).  The 95% confidence intervals overlap, 
which could imply that the odds ratio values may be equal for dermoscopy and non-
dermoscopy melanoma diagnoses.  There was no significant difference in diagnostic 
accuracy arising from the use of different dermoscopy diagnostic algorithms.  Diagnostic 
accuracy of dermoscopy significantly depends on the degree of experience of the 
examiners, with odds ratio 3.8 (95% CI: 3.3 - 4.3) for experts versus 2.0 (95% CI: 1.4 - 
2.6) for non-experts (p = .001).   
 The RCT by Westerhoff, McCarthy, and Menzies (2000) found that following a 
brief training intervention there was a significant improvement in both clinical diagnosis 
of melanoma and in diagnosis of melanoma using dermoscopy.  The improvement was 
significantly larger for the use of dermoscopy compared to clinical diagnosis alone.  
 In the last few years, three meta-analyses and two randomized studies have 
concluded that dermoscopy has an increased sensitivity for detecting melanoma when 
compared to the naked-eye examination (Carli et al., 2004).  The last piece of evidence 
provided by Vestergaard et al. (2008) was a meta-analysis done on dermoscopy studies 
performed in clinical settings.  The relative diagnostic odds ratio for melanoma was 15.6 
(p = .0016) for dermoscopy compared to naked-eye examination alone.  The average 
sensitivities for melanoma of the naked eye and dermoscopy examinations were 74% and 
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90% respectively.  The results suggest that there was better melanoma detection without 
increasing the number of unnecessary excisions of benign lesions.    
 Based on findings in this literature review, dermoscopy should be used only by 
trained examiners.  Providers not trained in dermoscopy will not experience good results 
from the use of dermoscopy.  The evidence supports the training of DHPs on the practice 
of using dermoscopy for the early detection of melanoma.  
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Chapter 3: Methodology 
 In this chapter, the design and methodology are explained.  The design is an 
interventional one-group before-and-after study.  The purpose of this evidenced-based 
project is to evaluate the effectiveness of an office-based dermoscopy training program 
for DHPs to improve their technique of performing clinical skin examinations for the 
early detection of melanomas.    
Sample 
 The sample consisted of one board certified dermatologist, one dermatology 
certified nurse practitioner, and one certified physician assistant.  All participants worked 
in dermatology for two years or greater, and have worked at the dermatology practice for 
at least 6 months seeing general dermatology patients.  The dermatologists, nurse 
practitioners, and physician assistants that worked at the dermatology practice and agreed 
to participate in the study are included in the study.  The exclusion criteria included 
medical doctors, physician assistants, and nurse practitioner students completing clinical 
hours in dermatology at the dermatology practice as well as new dermatologists, 
physician assistants, or nurse practitioners joining the practice after December 2010. 
 After approval was obtained from the University of North Florida Institutional 
Review Board (IRB), a date and time for the four-hour dermoscopy training course was 
determined.  The training course was held at the dermatology practice, and presented by a 
dermoscopist expert (see Appendix A for the “Abbreviated Curriculum Vita of the 
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Expert”).  Each participant was given a DermLite 3Gen DL100 at the completion of the 
course to use in their practice when conducting clinical skin examinations.  Informed 
consent was obtained prior to completing any study related activities.  Participation in the 
study was voluntary, and participants could chose to take part in the study or stop at any 
time.   
Methods 
 The interventional, one-group before-and-after study design consisted of the 
following: 
1.  The primary investigator conducted a retrospective review of the pathology   
      logs for each provider.  The time frame for the review was a three-month  
      period in 2010 from the same time frame that the study was conducted   
      in 2011.  
2.  A designated code number was assigned to each DHP by the primary  
     investigator.  All pathology information was assigned a code.  All Health  
     Insurance Portability and Accountability Act information was 
     honored.  Data on individual patients was used in aggregate form only. 
 3.  All DHP participants attended a four-hour training workshop that included   
                 pattern analysis recognition using dermoscopy. (See Appendix B for the  
                 “Dermoscopy Course Curriculum”.)  
 4.  Following the workshop, each DHP was given a DermLite 3Gen DL100 to  
                 use in practice when performing clinical skin examinations.  Each DHP  
                 completed a data collection sheet (see Appendix C for the “Data Collection  
                 Sheet”) to document their pattern of decision-making with and without a  
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                  DermLite.   
5.  Pathology logs of the three-month period of time following the workshop were  
     assessed for the type of lesions biopsied by participating DHPs.  The  
     pathology logs from the nurse practitioner who was using dermoscopy prior to  
     the workshop was included in the assessment.   
The outcome of interest was the use of dermoscopy by DHPs to demonstrate  
an increased detection of  melanoma when compared to naked-eye examination.  This 
outcome was evaluated 12 weeks post-workshop training.   
Time Frame 
 The time frame for this study was 14 weeks.  The study began once approval was 
obtained from the University of North Florida IRB.  The workshop date and time was 
announced to the DHPs; written informed consent was obtained from all participating 
DHPs  (see Appendix D for  the “Informed Consent”); and, the four- hour training course 
was held on a Saturday for the participating DHPs who agreed to participate in the study.  
Project Evaluation Plan 
 The data collection sheets were evaluated by the investigator to determine if 
dermoscopy raised or lowered the index of suspicion in equivocal lesions examined by 
DHPs.  The three-month block of histopathological data obtained pre-intervention was 
compared to the three-month block of histopathological data obtained post-intervention. 
The objectives for the project included 
• post-intervention histopathological data would show an increase in the 
number of melanomas detected using dermoscopy; 
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• dermoscopy would raise the level of suspicion in equivocal lesions 
examined by DHPs; and 
•  the use of dermoscopy would become the standard of care for DHPs 
employed at the Dermatology and Laser Center.  
Feasibility 
The project was designed to improve the quality of care for patients receiving a 
clinical skin examination (CSE).  It is of the utmost importance that the best evidence-
based tools available in the field of dermatology are used during a patient CSE.  When 
melanoma is diagnosed early, patients have the best chance of survival.  Patients 
diagnosed early with melanoma are usually able to avoid extensive and costly procedures 
with general surgery, sentinel lymph node biopsy, oncology visits, radiation, and repeat 
computed tomography.  
At the time of the study, the use of dermoscopy for CSE’s was not the standard of 
care in dermatology in the United States or in the practice where the data was collected.  
Income and Expenses 
The DHPs did not pay for any study related expenses.  They were not 
compensated for their time or any expenses related to completing the dermoscopy 
training workshop.  The dermoscopy workshop was held on a Saturday to avoid 
interference with patient care during the week.  Detailed expense report (see Appendix E 
for “Reported Expenses”). 
Institutional Review Board 
 IRB approval was granted by the University of North Florida (see Appendix F for 
“IRB Approval Documents”).  A letter of permission to complete the study at the 
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Dermatology and Laser Center was obtained from the owner of the center (see Appendix 
G for the “Permission Letter” form). 
Benefits and Risks 
 The benefit-risk ratio was assessed for this study and it indicated minimal risk and 
potential benefits, which included 
• a free four-hour dermoscopy training course given by a dermoscopy expert; 
• a free DermLite 3Gen DL100 used during the study, given to all DHPs who 
consented to participate; 
• an improvement in the ability to differentiate skin lesions and to initiate the 
appropriate treatment; 
• a decrease in the number of unnecessary procedures performed; and 
• an increase in the quality of care given to patients with potential life-threatening 
skin lesions.   
Confidentiality 
 All study source documents were kept confidential.  Data collected during the 
study was scanned and uploaded to a secure electronic server at the University of North 
Florida.  The secure server is password protected and available only to the investigator.  
After all study information was scanned, the source documents were shredded. 
Data Analysis 
 Descriptive statistics were utilized to summarize the collected data.  A computer-
assisted statistical analysis was done using SAS9.2 software.  Categorical variables 
were described using percentages and counts, while interval variables were described 
using median and interquartile range (IQR).  To evaluate the extent of agreement between 
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naked-eye examination as it compared to DermLite examination, Fleiss’s Kappa 
coefficient and Gwet’s AC1 coefficient were calculated. 
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Chapter 4: Data Analysis 
 This chapter describes the project and results.  The project objectives as outlined 
in Chapter Three are evaluated.  All DHPs working at the Dermatology and Laser Center 
were potential participants.  Out of four total possible participants, three entered the 
study.   
Statistical Analysis 
Statistical analysis was conducted using SAS9.2 software.  Descriptive statistics 
were used for demographical information.  Categorical variables were described using 
percentages and counts, while interval variables were described using median and 
interquartile range (IQR). 
To evaluate the extent of agreement between the use of DermLite and the naked 
eye, Fleiss’s kappa coefficient and Gwet’s AC1 coefficient were calculated.  The AC1 is 
not affected by the rater’s classification and trait prevalence of the subjects, contrary to 
the kappa statistics, and still adjusts for chance agreement.  Coefficients were interpreted 
using Fleiss’ benchmarking scale (1981).  Coefficient values ranging between 0 - 40% 
represent “Poor” extent of agreement, values in the 40% - 75% range represent an 
“Intermediate to Good” extent of agreement, while all kappa values in the 75% - 100% 
range indicate an “Excellent” extent of agreement.  Proportion of change in evaluations 
when using DermLite compared to the naked eye were calculated for each provider, 
along with an exact 95% confidence interval. 
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Implementation 
 This project began with the three DHPs attending a four-hour educational work 
shop on dermoscopy held Saturday June 11, 2011, at eight o’clock in the morning at the 
Dermatology and Laser Center in Orange Park, Floirda.  The workshop was given by Dr. 
Chavez-Frasier.  A power point presentation was used to aid in the review of basic 
dermoscopy.  During the interactive parts of the workshop, the DHPs were required to 
review 11 cases and to determine the risk that they associated with the lesion using the 
scale of “low”, “intermediated”, or “high”.  They had to diagnose the lesion type and 
state their disposition.  The DHPs had to use the pattern analysis algorithm that was 
reviewed during the workshop to determine melanocytic lesions from non-melanocytic 
lesions and decide if they would perform a biopsy or not.  Following the workshop, the 
project material was reviewed to include the project timeline.  All DHPs were given a 
DermLite 3Gen DL100 for their use while they participated in the project.  Each DHP 
completed forty data collection sheets in order to evaluate their use of the DermLite while 
completing a full-body skin examination as it compared to a naked-eye examination. 
  Project Objectives 
 The first objective was that post-intervention histopathological data would show 
an increase in the number of melanomas detected using dermoscopy.  There was an 
increase in the number of melanomas detected by the dermatologist; the nurse 
practitioner had a small increase, while the physician assistant had a decrease noted by 
post-intervention histopathological data.  A key barrier to this objective was the changes 
made to the schedules this summer in order to accommodate the cosmetic caseload of the 
practice.  The physician assistant had a decrease in the number of medical patients that 
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she would usually see over a three-month time period.  The dermatologist experienced an 
increase in the number of general dermatology patients and the nurse practitioner 
experienced a decrease in the number of general dermatology patients seen in a day when 
2010 totals were compared to 2011 totals.  The total number of biopsies performed was a 
key facilitator as they related to the number of melanomas detected.     
 The second objective was that dermoscopy would raise the level of suspicion in 
equivocal lesions examined by DHPs.  The facilitator that helped achieve this objective 
was the dermoscopy workshop, and the dermoscopic criteria that were employed during 
the clinical exam using a DermLite.  A healthcare provider does not want to misdiagnose 
melanoma on a patient.  The workshop demonstrated how important it is to use a 
DermLite to be able to see with cross-polarization pigmented networks and variety of 
color to help determine whether or not to biopsy suspicious lesions.  This diagnosis is 
very important, as when melanoma is involved it can mean the difference between life 
and death.  Fear of change was a key barrier expressed by the dermatologist participating 
in the project.   
 In the third objective, dermoscopy would become a standard of care for DHPs 
employed at the Dermatology and Laser Center.  This objective was not achieved, as 
evidenced by the dermatologist and physician assistant discontinuing use of the DermLite 
once the project data collection was completed.  This may or may not change once they 
are able to review project results.  A key barrier to this objective not being met was that 
one of the dermatologists declined to participate in the project due to his prior 
commitment to working Saturdays at another dermatology office.  Without this 
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dermatologist’s use of the DermLite at the practice, the standard of care will not be 
dermoscopy use.  
Unintended Consequences 
 The investigator’s plan of obtaining project data following the dermoscopy 
training workshop was detained at different time points.  Scheduling issues with the 
physician assistant made collecting data difficult.  The physician assistant had several 
cosmetic training workshops to attend, which decreased the amount of time she was 
available to see general dermatology patients.  Scheduled vacation time also conflicted 
with data collection. 
 A decrease in the number of patients seen in the summer of 2011 was significant 
when compared to the number of patients seen summer of 2010.  This is reflected in the 
number of patients presenting for skin examinations.  Specialty co-pay amounts may 
have played a role in the decreased number of patients scheduling appointments.  New 
issues related to healthcare reform and the increased unemployment rate may have also 
caused a decrease in the usual patient flow for the practice. 
Demographics 
There were 120 cases examined between the three DHPs.  Each DHP examined 
40 cases independent of each other over a three-month period of time in 2011.  The 
demographic information related to the cases is listed in Table 1. 
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Table 1 
  
Demographics 
 
Variable Percentage (Count)* 
Gender  
   Male 49% (59) 
   Female 51% (61) 
Age (Median, IQR) 60 years, 47 – 70 years 
Race  
   Caucasian 99% (119)  
   African-American 1% (1) 
Phototype (skin type)  
   Phototype I-II 58% (69) 
   Phototype III-IV 42% (51) 
Familiarity (family History)  
   Yes 20% (24) 
   No 80% (96) 
Previous melanoma  
   Yes 12% (14) 
   No 88% (106) 
Cancer history  
   Yes 42% (50) 
   No 58% (70) 
Number of Nevi  
   Less than 30 91% (109) 
   More than 30 9% (11) 
*Otherwise specified for Age 
 
Evaluation of the Level of Risk  
Overall, there were 120 evaluations made with DermLite compared to the naked 
eye.  The evaluations of risk made using DermLite and naked eye are presented in Table 
2.  The overall agreement was 0.52, the AC1 coefficient (95% CI) was 0.36 (0.30, 0.42),       
p < .001, and the kappa coefficient (95% CI) was 0.27 (0.20, 0.43), p < .001.  The 
estimate of the AC1 coefficient was typically larger than the kappa coefficient because of 
the sensitivity of kappa to the unequal trait prevalence in the population, but both 
indicated “Poor” agreement between the two methods. 
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Table 2 
 
Evaluations of the Level of Risk 
 
Method Low Intermediate High 
Naked eye 41% (49) 45% (54) 14% (17) 
DermLite 44% (53) 34% (41) 22% (26) 
Raw Agreement .52 
Kappa Coefficient 0.27 (95% CI: 0.20, 0.43) 
AC1 Coefficient 0.36 (95% CI: 0.30, 0.42) 
 
Overall, the risk of a lesion under exam being suspect for skin cancer was higher 
on 27.5% (33 out of 120) of the evaluations and lower on 20.8% (25 out of 120) of the 
evaluations.  The risk of a lesion was evaluated the same on 51.7% (62 out of 120) of the 
evaluations (Table 3).  
The proportion of changes in evaluation of risk made by Provider 1 using 
DermLite compare to naked eye was 0.23 (95% CI: 0.11, 0.38).  Provider 2 had changed 
the evaluation of risk in proportion of 0.88 (95% CI: 0.73, 0.96) when using DermLite. 
Provider 3 had changed the evaluation of risk in proportion of 0.35 (95% CI: 0.21, 0.52) 
when using DermLite (Table 3). 
 
Table 3 
 
Evaluations Using the Naked Eye Compared to DermLite 
 
 Provider 1 Provider 2 Provider 3 Overall 
Agreement 77.5% (31) 12.5% (5) 65.0% (26) 51.7% (62) 
Change 22.5% (9) 87.5% (35) 35.0% (14) 48.3% (58) 
    Increased  suspicion 17.5% (7) 35.0% (14) 30.0% (12) 27.5% (33) 
    Decreased suspicion   5.0% (2) 52.5% (21)   5.0% (2) 20.8% (25) 
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Diagnosis 
The diagnosis made using DermLite compared to the naked eye are presented in 
Table 4. The overall agreement was 0.72, AC1 coefficient (95% CI) was 0.75 (0.71, 
0.79), p < 0.001, and the kappa coefficient (95% CI) was 0.73 (0.68, 0.78), p < .001.  
Both coefficients provided an “Intermediate to Good” agreement between the two 
methods in assigning a diagnosis.  The diagnosis made included dysplastic nevus, 
seborrheic keratosis (SK), basal cell carcinoma (BCC), squamous cell carcinoma (SCC), 
melanoma and other lesions noted but were not include on the data collection sheet. 
Table 4 
 
Diagnosis Using the Naked Eye and DermLite 
 
Method Dysplastic 
Nevus 
SK BCC SCC Melanoma Other 
Naked eye 28% (34) 15% 
(18) 
17% 
(20) 
2% 
(2) 
7% (8) 32% 
(38) 
DermLite 31% (37) 15% 
(18) 
13% 
(16) 
3% 
(3) 
6% (7) 39% 
(32) 
Raw Agreement .79 
Kappa 
Coefficient 
0.73 (95% CI: 0.68, 0.78) 
AC1 Coefficient 0.75 (95% CI: 0.71, 0.79) 
 
Overall, the diagnosis was considered more serious on 10.8% (13 out of 120) of 
the evaluations and less serious on 10% (12out of 120) of the evaluations.  The same 
diagnosis was pronounced on 79.2% (95 out of 120) of the evaluations (Table 5).  
The proportion of changes in diagnosis by Provider 1 using DermLite compared 
to the naked eye was 0.08 (95% CI: 0.02, 0.20).  Provider 2 had changed the diagnosis in 
proportion of 0.38 (95% CI: 0.23, 0.54) when using DermLite.  Provider 3 had changed 
the diagnosis in proportion of 0.18 (95% CI: 0.07, 0.33) when using DermLite (Table 5). 
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Table 5 
 
Diagnosis Using the Naked Eye Compared to DermLite 
 
 Provider 1 Provider 2 Provider 3 Overall 
Agreement 92.5% (37) 62.5% (25) 82.5% (33) 79.2% (95) 
Change 7.5% (3) 37.5% (15) 17.5% (7) 20.8% (25) 
    Increased  suspicion 2.5% (1) 27.5% (11)    2.5% (1) 10.8% (13) 
    Decreased suspicion 5.0% (2) 10.0% (4)  15.0% (6) 10.0% (12) 
 
Disposition 
The disposition made using DermLite compared to the naked eye are presented in 
Table 6.  The overall agreement was 0.66, the AC1 coefficient (95% CI) was 0.51 (0.43, 
0.56), p < .001, and the kappa coefficient (95% CI) was 0.47 (0.40, 0.53), p < .001.  Both 
coefficients provided an “Intermediate to Good” agreement between the two methods in 
assigning a disposition.  
 
Table 6 
 
Disposition Using the Naked Eye and DermLite 
 
Method No intervention Follow-up Pathology 
Naked eye 23% (27) 38% (45) 40% (48) 
DermLite 22% (26) 27% (32) 52% (37) 
Raw Agreement .66 
Kappa Coefficient 0.47 (95% CI: 0.40, 0.53) 
AC1 Coefficient 0.51 (95% CI: 0.43, 0.56) 
 
 
Overall, the disposition was considered more serious on 20.8% (25 out of 120) of 
the evaluations and less serious on 13.3% (16 out of 120) of the evaluations.  The same 
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disposition was given on 65.8% (79 out of 120) of the evaluations (Table 7).  The 
proportion of changes in disposition by Provider 1 using DermLite compared to the 
naked eye was 0.15 (95% CI: 0.06, 0.30).  Provider 2 had changed the disposition in 
proportion of 0.58 (95% CI: 0.41, 0.73) when using DermLite.  Provider 3 had changed 
the disposition in proportion of 0.30 (95% CI: 0.17, 0.47) when using DermLite (Table 
7). 
 
Table 7 
 
Disposition Using the Naked Eye Compared to DermLite 
 
 Provider 1 Provider 2 Provider 3 Overall 
Agreement 85.0% (34) 42.5% (17) 70.0% (28) 65.8% (79) 
Change 15.0% (6) 57.5% (23) 30.0% (12) 34.2% (41) 
    Increased  suspicion 12.5% (5) 25.0% (10) 25.0% (10) 20.8% (25) 
    Decreased suspicion   2.5% (1) 32.5% (13)   5.0% (2) 13.3% (16) 
 
Histopathological Data   
 Aggregated data from 2010 and 2011 was collected from the same time period 
that represented the three-month period of time in which the study was completed.  This 
data is descriptive only between the two time periods (Table 8). 
 Table 8 
Histopathological Data 
 
 June 2010- August 2010  June 2011- August 2011 
 Provider 1  Provider 2 Provider 3  Provider 1 Provider 2 Provider 3 
Total # of 
melanoma     
 
 
5 
 
1 
 
5 
  
8 
 
0 
 
6 
Number of pts 
seen 
 
1,400 500 2,160  1,300 420 1,620 
Biopsies done 118 98 208  185 73 254 
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Chapter 5: Discussion 
 This chapter provides a discussion of the implementation of dermoscopy, looking 
at dermoscopy use in clinical practice at the Dermatology and Laser Center by DHPs 
when they perform clinical skin examinations for the early detection of melanoma.  This 
discussion will include the limitations, implications, and recommendations for future 
practice.  
Discussion 
 Skin cancer is more common than any other cancer, melanoma accounting for 
five percent of skin cancer cases.  For melanoma to represent such a small percent, the 
majority of skin cancer deaths are from melanoma.  New melanoma cases are estimated 
to be 70, 230.  The incidence rate for melanoma has been rising for 30 years (ACS, 
2011).  Melanoma presents a substantial clinical challenge to healthcare providers.  The 
early detection of this skin cancer provides patients with the best chance for a cure. 
 Dermoscopy is an important part of the clinical skin examination.  Studies suggest 
clinicians learn to use a DermLite in order to integrate dermoscopy into clinical practice 
to improve patients’ outcomes.  Being able to differentiate melanocytic from non-
melanocytic skin lesions is the foundation upon which dermoscopic diagnosis is built 
(Bowling et. al., 2007).      
The purpose of this project was to evaluate the effectiveness of a practice-based 
dermoscopy training program for dermatology healthcare providers in order to improve 
their technique of performing clinical skin exams for the early detection of melanomas. 
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This project was conducted in a private practice dermatology office in Florida.  Patients 
in the state of Florida have open access to dermatological care.  Most patients do not 
utilize this open access appropriately for preventative services.  Patients frequently seek 
care when they have a problem or concern or have had a friend or loved one diagnosed 
with malignant melanoma.        
 Results of this project demonstrated a “Poor” agreement between the two methods 
when the level of risk was evaluated.  Diagnosis and disposition using the two methods 
provided an “Intermediate to Good” agreement.  Theses results only look at agreement 
between examinations when the naked eye was compared to the DermLite for the 
individual providers in the study.  The providers did not examine the same cases and 
without histopathological confirmation of the identified lesions documented by the 120 
cases reviewed, there was no way to confirm sensitivity and specificity for the Dermlite 
versus the naked eye.    
 Histopathological data identified melanoma for the time period reviewed in 2010, 
which was then compared to the time period of the study for 2011.  There was a 
difference in the number of melanomas seen in the 2010 aggregated data compared to the 
2011 aggregated data.  The cases identified during the project were not confirmed using 
histopathological data as standard criteria.    
Limitations  
 The main limitation of this project was not being able to compare 
histopathological data that was obtained from the 120 cases.  Without histopathological 
confirmation, there was no way to confirm if dermoscopy increased the detection of 
melanoma.  Second, aggregated data demonstrated an increased incidence of melanomas 
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after the dermoscopy training compared to the number of melanomas identified prior to 
training of DHPs in the area of dermoscopy.  Aggregated data is a limitation for this 
study since there is no way to confirm information obtained during this project.  Lastly, 
the skin examinations should have been limited to patients with pigmented skin lesions or 
a previous history of dysplastic nevi, which would help better understand the benefits of 
dermoscopy.       
Implications for Future Practice 
 The project design for this evidence-based project was different than the studies 
identified in the literature.  The project design was chosen because it was a good fit for 
the practice where the investigator works.  Many studies demonstrated the positive 
benefit of using dermoscopy for the early detection of melanoma.  All studies in the 
literature pointed out that training was required in order for dermoscopy to be able to 
achieve improvement in diagnostic accuracy.   
 This project did not produce the results that the investigator expected to obtain.  
In order to determine if dermoscopy would increase the detection of melanoma when 
compared to naked eye examination by DHPs, comparisons of a single lesion on a patient 
by all providers should be made in order to determine the sensitivity and specificity of 
dermoscopy use. 
 The investigator recommends revision of the protocol to include the use of 
histopathological data as standard criteria in confirming diagnosis made with 
dermoscopy.  DHPs would each evaluate a single lesion on the same patients and 
complete their own data collection sheet.  This method of data collection would allow for 
comparison among all providers on each lesion, with confirmation by histopathological 
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evaluation.  This method would allow the determination of dermoscopy versus naked-eye 
examinations with confirmation.  Patient type for the project would be limited to those 
patients with pigmented skin lesion or a history of dysplastic nevi.      
Recommendations 
 The practice strategic plan includes keeping up with the latest advancements in 
dermatology in order to provide patients with the most up-to-date services available. 
The use of dermoscopy fits into the strategic plan of the practice.  All providers at the 
Dermatology and Laser Center need to be involved in future projects.  Consecutive 
patients seen in the practice who present a concern for a pigmented skin lesion or have a   
history of dysplastic nevi would be examined.  
 This project could easily be reproduced in family practice.  Family practice 
providers see patients with a concern of skin lesions daily.  Having the ability to triage all 
patients with concerns of a pigmented skin lesion is an important assessment skill for 
family practice providers.  Melanoma is a serious form of skin cancer when not detected 
early and can result in death.  
Conclusion  
 The investigator’s knowledge of an evidence-based practice change project was 
very limited at the start of this project.  While the investigator realized the importance of 
evidence-based practice as it relates to how patients are cared for in clinical practice,  this 
does not compare to completing a project based on the evidence.  The networking that the 
investigator had to partake in was time consuming and a lot of hard work.  Taking care of 
all the details on the front end ensured that the project would start and finish based on the 
timeline established.       
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 The providers at the Dermatology and Laser Center who participated in the 
project change were excited and eager to use dermoscopy in practice.  This was evident 
by the questions that were asked during the dermoscopy workshop.  Their cooperation 
with completing data collection sheets during the project was also evident.  The 
investigator has hopes that the providers will use reference books on dermoscopy that are 
available at the practice to continue to increase their knowledge of dermoscopy. 
Continued self-directed learning is imperative, since dermoscopy is a different language 
full of particular terms varying in meaning depending on any given lesion that is 
evaluated.  
 During the project it was evident that patients had a sense of reassurance when the 
providers’ use the DermLite to reevaluate what was seen by the naked eye.  Some of the 
patients commented on the light and wanted to know how it worked.  The providers were 
more than happy to explain the features of the DermLite. 
 More studies are needed to provide better evidence on the value of dermoscopy in 
clinical practice at the Dermatology and Laser Center.  Future projects should be more 
explicit in regards to methods used and lesion selection in order to better understand the 
benefits of dermoscopy.  Completion of a project that would allow further assessment of 
intraobserver and interobserver variability combined with assessment of the impact of 
training could prove positive results.  Potential clinical benefits and limitations of 
dermoscopy at the Dermatology and Laser Center need to be more clearly understood. 
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Appendix A: Abbreviated Curriculum Vita of the Expert 
Arianne E Chavez-Frazier, M.D. 
 
Curriculum Vitae 
 
PERSONAL DATA 
 
    Email:   txdermdoc@yahoo.com 
 
Current Position: Procedural Dermatology/Mohs Surgeon 
                      Park Avenue Dermatology 
                      Orange Park, FL                          
                                       
 
CERTIFICATIONS 
            Clinical Staff:  Orange Park Medical Center 
                                                 
Board Certified: American Board of Dermatology  
 
Fellowships: AGME Procedural Dermatology/Mohs    
                                                          Fellowship 
Mohs Micrographic Surgery and Reconstruction.  
 Dayton Skin Surgery Center/Wright State University 
Psoriasis and Phototherapy Clinical Research Fellowship 
    University of California San Francisco 
    Department of Dermatology 
 
Medical License:   Florida – active and current 
 
WORK 
  
1/11 – present             Park Avenue Dermatology P.A. 
                                    906 Park Avenue, Orange Park, FL 32073 
   Employee: Procedural Dermatologist/Mohs Surgeon  
 
 
10/09- 1/11             Dayton Skin Surgery Center 
               3025 Governor’s Place Blvd. Kettering, OH 45409 
                                    Employee: Procedural Dermatologist/Mohs Surgeon  
      
 
 8/07-7/08  Advanced Dermatology 
    430 Mason Rd. Katy, TX 77450 
    Employee: Moonlighting Dermatologist Saturday clinic 
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   Appendix B: Dermoscopy Course Curriculum  
 
Basic Dermoscopy Course 
 
Objectives: 
 
 Dermatology healthcare providers will understand the benefits of dermoscopy. 
 Dermatology healthcare providers will learn to diagnose and manage skin lesions 
using dermoscopy.  
Course Content: 
 Interactive pre-test 
 Why Dermoscopy? 
 Two Step Algorithm to include Pattern Analysis 
 Global Features and Local Criteria  
 Melanocytic and Non-Melanocytic Lesions 
 Classification of Nevi 
 Melanoma Criteria 
 Cases 
 Interactive post-test 
 Questions 
 
Text Book: Dermoscopy: An Illustrated Self-Assessment Guide  
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Appendix C: Data Collection Sheet 
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I''&0&$95=!
B$++(90/------------------------------------------------------------------------------------!
Age_____    
Race:  Caucasian Black/African American Asian Hispanic Other  
Gender: M F     
Phototype: I-II  III-IV       
Total Number of Nevi:  < 30  >30 
Number of clinically atypical nevi: None 1-5 6-10  >10 
Familiarity: None Yes 
Previous Melanoma: No Yes 
Chief complaint: Full Skin Check Concern with a mole             
History of Skin Cancer: Yes No 
 
 
!
!
!
!
!
!
!
!
!
!
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Appendix D: Informed Consent 
INFORMED CONSENT 
 
1.  SOURCE OF RESEARCH:  This project is being conducted under the direction of the 
Department of Nursing, Brooks College of Health, at the University of North Florida. 
 
2.  TITLE OF RESEARCH:  Dermoscopy: An Evidenced-Based Approach for the Early 
Detection of Melanoma. 
 
3.  IRB NUMBER: __________________________ 
 
4.  PRIMARY INVESTIGATOR:  Angela Y Armstrong, MSN, FNP-BC, DCNP. 
 
5.  PARTICIPATION:  Participation is VOLUNTARY. Refusal to participate will 
involve no penalty or loss of benefits to which you would otherwise be entitled. If you 
refuse to participate or withdraw your consent there will be no consequences. No 
explanation will be requested for withdrawal from the study. You are not waiving any 
legal claims because of your participation in this study. If you have any questions 
regarding your rights as a research subject, you may contact Dr. Katherine Kasten, Chair 
UNF Institutional Review Board at 904 620 2498 for questions regarding the rights of 
research subjects. 
 
6.  PARTICIPANT CONFIDENTIALITY:  [Your information will remain confidential 
and only the researcher(s) will be able to tie your data to your identity by using a secure 
list containing a participant code that is linked to your responses. The researcher(s) will 
use a study number instead of your name when at all possible.] By signing this Informed 
Consent form you give permission for the use and disclosure of your information for 
purposes of this study at any time in the future.  
 
7.  RISK: [There are no foreseeable risks to you as a participant.] There is no cost for you 
to participant except for your time. Participants may contact the primary investigator 
Angela Y Armstrong by email at ayarn1@comcast.net. Email will be checked several 
times during each day and will remain active for six (6) months after the study is 
completed. Participants may also contact Ms. Armstrong by phone (904) 728 4733 from 
8:00 am to 5:00 pm Monday thru Friday for questions regarding the study or procedures 
related to the study. [For questions regarding the rights of research subjects you may 
contact Dr. Katherine Kasten, Chair of UNF’s Institutional Review Board at 904 620 
2498.] 
 
8.  PURPOSE: The purpose of this project is to evaluate the effectiveness of a practice 
based dermoscopy training program for dermatology healthcare providers in order to 
improve their technique of performing clinical skin exams for the early detection of 
melanomas. The study is expected to continue for three (3) months after the recruitment 
period which is expected to be two (2) weeks in duration. 
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9.  PROCEDURES:  If you decide to participate in this project, you will be asked to do 
the following: Attend a dermoscopy training course given by an expert in dermoscopy. 
The training course will be held on a Saturday and last approximately four hours. You 
will be given a derm lite following the training and asked to use the derm lite when you 
perform clinical skin exams in your daily practice. The PI will record your findings on a 
data collection sheet that will list your results with the derm lite and without the derm 
lite.   
 
10. BENEFITS TO PARTICIPANTS: The following are possible benefits to you:  
• A free four hour dermoscopy training course given by a dermoscopy expert. 
• [A derm lite 3Gen DL100 for the temporary use during this study] 
• An anticipated improvement in the ability to differentiate skin lesions and to 
initiate the appropriate treatment. 
• An anticipated decrease in the number of unnecessary biopsies performed.   
 
11. ALTERNATIVE TREATMENTS:  If you chose not to participate in this study you 
can continue to provide care as you always have in your daily practice. 
 
12. PAYMENT TO PARTICIPANTS:  There will be no direct monetary reimbursement 
for participation in this study. All items given to the participants during the study will 
remain with them at the end of the study. 
 
13. PARTICIPATION OF MINORS: No one under the age of 18 at the time of consent 
will be eligible to participate. 
 
14. PARTICIPANT CERTIFICATION:  
 
I  have read and I understand the information provided above. I have been given an 
opportunity to ask questions and all my questions have been answered to my satisfaction. 
I have been given a copy of this form.    
 
By signing this form, I willingly agree to participant in the research it describes. 
 
 
_____________________       _________________________           _______________ 
Name of Participant                 Signature of Participant                       Date 
 
 
 
I have explained the research to the subject, and answered all of his or her questions. I 
believe that he or she understands the information described in this document and freely 
consents to participate. 
 
Angela Armstrong                _________________________            ________________ 
Name of Investigator             Signature of Investigator                       Date       
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Appendix E: Reported Expenses 
Cost of Project 
Copies……………………………………………………………… 15.00 
Batteries for DermLites……………………………………………  25.00 
Cost for Expert…………………………………………………… 300.00 
Cost of Statistician………………………………………………...500.00  
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Appendix F: IRB Approval Documents 
 
 
 
 
 
 
~ 
UNF 
UNIVERSITY of 
NORTH FLORIDA. 
Office of Research and Sponsored Programs 
I UNFDrive 
Jacksonville, FL 32224-2665 
904-620-2455 FAX 904-620-2457 
Equal Opportunity/Equal Access/ Affirmative Action Institution 
MEMORANDUM 
TO: 
May 19, 2011 
Ms. Angela Armstrong 
Department ofNursing 
Dr. Katherine Kasten, Chairperson 
On behalf of the UNF Institutional Review Board 
Review by the UNF Institutional Review Board IRB#11-035: 
Dermoscopy: An Evidenced-Based Approach for the Early Detection of Melanoma 
This is to advise you that your project, "Dermoscopy: An Evidenced-Based Approach for the Early Detection of 
Melanoma" was reviewed on behalf of the UNF Institutional Review Board and was declared Exempt, Category 
2." Therefore, this project requires no further IRB oversight unless substantive changes are made. 
This approval applies to your project in the form and content as submitted to the IRB for review. Any variations 
or modifications to the approved protocol and/or informed consent forms as they relate to dealing with human 
subjects must be cleared with the IRB prior to implementing such changes. Any unanticipated problems 
involving risk and any occurrence of serious harm to subjects and others shall be reported promptly to the IRB 
within 3 business days. 
As you may know, CITI Course Completion Reports are valid for 3 years. Your completion report is valid 
through 11/07/2013 . If your completion report expires within the next 60 days or has expired, please take 
CITI' s refresher course and contact us to let us know you have completed that training. If you have not yet 
completed your CITI training or if you need to complete the refresher course, please do so by following this 
link: http: //www.citiprogram.org/. Based on your research interests we ask that you complete either the "Group 
1 Biomedical Research Investigators and Key Personnel" CITI training or the "Group 2 Social Behavioral 
Researcher Investigators and Key Personnel" CITI training. 
Should you have any questions regarding your project or any other IRB issues, please contact Kayla 
Champaigne at 904-620-2312, or K.Champaigne@unf.edu. 
UNF IRB Number: 11-035 
Approval Date: 05-19-2011 
Expiration Date: exempt- none 
Processed on behalf of UNF' s IRB  
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Appendix G: Permission Letter 
 
 
 
 
 
 
UNF ffi.B Number: 11-035 
Approval Date: 05-19-2011 
Expiration Date: exempt- none  ' 
Processed on behalf of UNF' s ffi.B  
2055 P((lfe$ona! <:enter Drive • Oraf1ge Paric, Rorida 32073 
.·.·• 904-27:6-4SOQ ~••· Ja:>e 9(}4-276-4160> • .~·derrnat'tliOfJYandtaser~enter.n~t 
Signature Deleted
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